Alexander N Kornetov (A N Kornetov)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Network Analysis

Bipolar Disorder

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Pharmaceuticals (Basel, Switzerland)

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Stanislav A Galkin, Elena G Kornetova, T A Oshkina, Alexander N Kornetov, V F Lebedeva, Nikolay A Bokhan
[The relationship between the functional state of the brain and clinical and constitutional factors in schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (2) (2024)
Elena G Kornetova, Stanislav A Galkin, Irina A Mednova, V V Tsiguntsev, Anastasiia S Boiko, Alexander N Kornetov, Svetlana A Ivanova, Nikolay A Bokhan
[Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (3) (2024)
Stanislav A Galkin, Elena G Kornetova, N N Azarenko, T A Oshkina, Alexander N Kornetov, Nikolay A Bokhan
[Electroencephalographic differences in patients with paranoid schizophrenia with or without a history of suicide attempts]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (5) (2024)
Anton J M Loonen, Taichi Ochi, Lisanne M Geers, German G Simutkin, Nikolay A Bokhan, Daniel J Touw, Bob Wilffert, Alexander N Kornetov, Svetlana A Ivanova
A New Paradigm to Indicate Antidepressant Treatments. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Evgeniya G Poltavskaya, Olga Yu Fedorenko, Elena G Kornetova, Anton J M Loonen, Alexander N Kornetov, Nikolay A Bokhan, Svetlana A Ivanova
Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms. Life (Basel, Switzerland) 11 (10) (2021)
Anastasiia S Boiko, Irina A Mednova, Elena G Kornetova, Valeria I Gerasimova, Alexander N Kornetov, Anton J M Loonen, Nikolay A Bokhan, Svetlana A Ivanova
Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)